PERSEVERANCE RESEARCH CENTER

Nicole is a seasoned leader in the clinical research industry, currently serving as CEO of Perseverance Research Center. With 27 years of research experience, she has a proven track record of driving successful clinical trials across diverse neurological diseases specializing in Epilepsy, Alzheimer’s Disease, Multiple Sclerosis, Mild Cognitive Impairment and Traumatic Brain Injury. Her expertise in study design, leadership, regulatory compliance, and patient recruitment has been instrumental in accelerating the development of innovative therapies.

In addition to obtaining her Masters in Health Sector Management with an emphasis in Epidemiology from the WP Carey School of Business at Arizona State University, Nicole received a Masters and PhD in Clinical Research from Texila American University. She has always been passionate about advancing patient care through rigorous clinical research practices and many of her research findings have been published in various medical journals. Finding a cure or a therapy that can ameliorate the lives of individuals who suffer from neurological disorders is Nicole's truest passion. Her PhD thesis focused on the importance of proper nutrition, decreasing inflammation and repairing cellular damage in patients with Alzheimer’s disease, and was published in the Journal of Clinical Trials

Laura Christians is a seasoned professional with 18 years of experience in clinical research, specializing in a wide array of therapeutic areas including oncology, cardiology, neurology, endocrinology, dermatology, and podiatry. A graduate of Arizona State University with a BS in Biology, Laura developed a passion for clinical pharmacology early on, a path that was further nurtured during a formative summer internship.

Throughout her career, Laura has worked across Phase II-IV clinical trials and developed extensive knowledge in both federal and international regulatory requirements. She is also a certified rater for the administration of clinical outcome rating scales, reflecting her commitment to maintaining high standards in clinical research.

Her deep expertise, hands-on experience, and dedication to innovation make her an invaluable leader in the clinical research field and the company’s operations.

With over a decade of experience in clinical research, Brandon has managed complex trials in diverse therapeutic areas, ensuring operational excellence and adherence to regulatory standards. His leadership at PRC combines strategic vision with a deep commitment to patient advocacy, fostering collaboration between researchers, clinicians, and pharmaceutical partners.

Allan Block, MD, has practiced neurology in Scottsdale since 1998 and joined PRC in 2017. He acts as PRC’s Medical Director and lead Principal Investigator, where he oversees PRC’s neurological research activities and conducts research in an objective and unbiased manner in compliance with policies and regulations.

Dr. Block is certified by the American Board of Psychiatry and Neurology in neurology. He earned his medical degree at Creighton University School of Medicine. He completed his neurology residency and neurophysiology fellowship at the Barrow Neurological Institute in Phoenix Arizona.

Dr. Block has served as a principal or co-investigator for more than 70 clinical studies and has been PI on many investigational devices and drugs that have made it to market.

Andrea Kessler is a dedicated nurse practitioner with over 24 years of diverse healthcare experience across various clinical settings. She is passionate about advancing medical research and serves as a sub-investigator and Principal Investigator for PRC, focusing on study infusions, pediatric migraine study assessments, as well as an EDSS assessor for patients undergoing neurological studies. Her expertise in nursing and compassionate care has been a tremendous asset to PRC.